Most Recent Additions*
Reducing Superfluous Opioid Prescribing Practices After Brain Surgery: It Is Time to Talk About Drugs
Karam Asmaro, Hassan A. Fadel, Sameah A. Haider, Jacob Pawloski, Edvin Telemi, Tarek Mansour, Ankush Chandra, Michael Bazydlo, Adam M. Robin, Ian Y. Lee, Ellen L. Air, Jack P. Rock, Steven N. Kalkanis, and Jason M. Schwalb
Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis
Indrani Datta, Houtan Noushmehr, Chaya Brodie, and Laila M. Poisson
Commentary: Single-Position Surgery: Prone Lateral Lumbar Interbody Fusion: 2-Dimensional Operative Video
Seokchun Lim and Victor Chang
Imaging acute effects of bevacizumab on tumor vascular kinetics in a preclinical orthotopic model of U251 glioma
Tavarekere N. Nagaraja, Rasha Elmghirbi, Stephen L. Brown, Julian A. Rey, Lonni Schultz, Abir Mukherjee, Glauber Cabral, Swayamprava Panda, Ian Y. Lee, Malisa Sarntinoranont, Kelly A. Keenan, Robert A. Knight, and James R. Ewing
Prognostic significance of genome-wide DNA methylation profiles within the randomised, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma
C. M.S. Tesileanu, M. J. van den Bent, M. Sanson, W. Wick, A. A. Brandes, P. M. Clement, S. C. Erridge, M. A. Vogelbaum, A. K. Nowak, J. F. Baurain, W. P. Mason, H. Wheeler, O. L. Chinot, S. Gill, M. Griffin, L. Rogers, W. Taal, R. Rudà, M. Weller, C. McBain, M. E. van Linde, Thais S. Sabedot, Y Hoogstrate, A von Deimling, I de Heer, W. F.J. van IJcken, R. W.W. Brouwer, K. Aldape, R. B. Jenkins, H. J. Dubbink, J. M. Kros, P. Wesseling, K. J. Cheung, V. Golfinopoulos, B. G. Baumert, T. Gorlia, H. Noushmehr, and P. J. French
Plasminogen deficiency causes reduced angiogenesis and behavioral recovery after stroke in mice
Jinghuan Fang, Michael Chopp, Hongqi Xin, Li Zhang, Fengjie Wang, William Golembieski, Zhenggang Zhang, Li He, and Zhongwu Liu
Repeated Mechanical Endovascular Thrombectomy for Recurrent Large Vessel Occlusion: A Multicenter Experience
Ghada A. Mohamed, Hassan Aboul Nour, Raul G. Nogueira, Mahmoud H. Mohammaden, Diogo C. Haussen, Alhamza R. Al-Bayati, Thanh N. Nguyen, Mohamad Abdalkader, Artem Kaliaev, Alice Ma, Johanna Fifi, Jacob Morey, Dileep R. Yavagal, Vasu Saini, Santiago Ortega-Gutierrez, Mudassir Farooqui, Cynthia B. Zevallos, Darko Quispe-Orozco, Lonni Schultz, Max Kole, Daniel J. Miller, Stephan A. Mayer, Horia Marin, and Alex B. Chebl
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin
Steven L. Flamm, Kimberly Brown, Hani M. Wadei, Robert S. Brown, Marcelo Kugelmas, Milagros Samaniego-Picota, Patrizia Burra, Fred Poordad, and Sammy Saab
Right Ventricular Dysfunction and Adverse Outcomes after Renal Transplantation
Megan S. Joseph, Francis Tinney Jr., Abhijit Naik, Raviprasenna Parasuraman, Milagros Samaniego-Picota, and Nicole M. Bhave
Transplant administration-A survey of the roles and responsibilities of kidney and pancreas medical directors of US transplant centers
Neeraj Singh, John Friedewald, Roy Bloom, Darshana Dadhania, Ronald F. Parsons, Bruce Kaplan, Milagros Samaniego-Picota, Yasir Qazi, Mona Doshi, Gwen McNatt, Muhammad Saad Naseer, Todd Pesavento, and Alexander Wiseman
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
David C. Wheeler, Robert D. Toto, Bergur V. Stefansson, Niels Jongs, Glenn M. Chertow, Tom Greene, Fan Fan Hou, John J.V. McMurray, Roberto Pecoits-Filho, Ricardo Correa-Rotter, Peter Rossing, C. David Sjöström, Kausik Umanath, Anna Maria Langkilde, and Hiddo J.L. Heerspink
Relative Predictive Value of Circulating Immune Markers in US Adults Without Cardiovascular Disease: Implications for Risk Reclassification
Kartik Gupta, Rajat Kalra, Mike Pate, Shivaraj Nagalli, Sameer Ather, Indranee Rajapreyar, Pankaj Arora, Ankur Gupta, Wunan Zhou, Raul San Jose Estepar, Marcelo Di Carli, Sumanth D. Prabhu, and Navkaranbir S. Bajaj
Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication
Jordan K. Schaefer, Josh Errickson, Yun Li, Xiaowen Kong, Tina Alexandris-Souphis, Mona A. Ali, Deborah Decamillo, Brian Haymart, Scott Kaatz, Eva Kline-Rogers, Jay H. Kozlowski, Gregory D. Krol, Sahana R. Shankar, Suman L. Sood, James B. Froehlich, and Geoffrey D. Barnes
Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures
Muhammad Adil Sheikh, Xiaowen Kong, Brian Haymart, Scott Kaatz, Gregory D. Krol, Jay Kozlowski, Musa Dahu, Mona Ali, Steven Almany, Tina Alexandris-Souphis, Eva Kline-Rogers, James B. Froehlich, and Geoffrey D. Barnes
Antimicrobial stewardship programs in adult intensive care units in Latin America: Implementation, assessments, and impact on outcomes
Rodolfo E. Quirós, Ana C. Bardossy, Patricia Angeleri, Jeannete Zurita, Washington R. Aleman Espinoza, Marcelo Carneiro, Silvia Guerra, Julio Medina, Ximena Castañeda Luquerna, Alexander Guerra, Silvio Vega, Luis E. Cuellar Ponce de Leon, José Munita, Elvio D. Escobar, Gina Maki, Tyler Prentiss, and Marcus J. Zervos
Tissue-specific role and associated downstream signaling pathways of adiponectin
Bipradas Roy and Suresh S. Palaniyandi
Common Complications of Sickle Cell Disease: A Simulation-Based Curriculum
Cassondra Cramer-Bour, Justin Peterson, Barbara Walsh, and Elizabeth S. Klings
Patient-Reported Outcomes in the Era of Immunotherapy Trials
Shirish M. Gadgeel
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Angel Qin, Songzhu Zhao, Abdul Miah, Lai Wei, Sandipkumar Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Peter G. Shields, Gregory P. Kalemkerian, Shirish M. Gadgeel, Nithya Ramnath, Bryan J. Schneider, Khaled A. Hassan, Nicholas Szerlip, Zoey Chopra, Sara Journey, Jessica Waninger, Daniel Spakowicz, David P. Carbone, Carolyn J. Presley, Gregory A. Otterson, Michael D. Green, and Dwight H. Owen
Editorial: Changing trends in the US prevalence of hepatitis B core antibody provide important perspectives into future screening and vaccination strategies
Humberto C. Gonzalez, Sheri Trudeau, and Stuart C. Gordon
*Updated as of 05/18/21.
